| Financial Year |
March 31 2023 |
| Monetary Funds |
183,006,432.65 |
| Held-for-trading Financial Assets |
130,000,000.00 |
| Notes Receivable |
22,568,506.53 |
| Accounts Receivable |
102,864,584.16 |
| Advances to Suppliers |
3,283,266.71 |
| Other Receivables |
17,563,694.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,253,914.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,569,724.67 |
| Total Current Assets |
469,110,124.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
243,264,019.28 |
| Investment Properties |
206,116,171.36 |
| Fixed Assetes |
2,179,185,053.68 |
| Under-construction Projects |
99,242,413.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,097,428,388.46 |
| R&D expenses |
-- |
| Goodwill |
66,574,137.00 |
| Long-Term Deferred and Prepaid Expenses |
14,117,483.26 |
| Deferred Income Tax Assets |
6,219,773.88 |
| Other Non-Current Assets |
207,560,699.62 |
| Sub-Total of Non-Current Assets |
4,241,303,349.98 |
| Total Assets |
4,710,413,474.52 |
| Short-Term Loans |
218,750,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
39,993,638.28 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
32,072,072.67 |
| Taxes Payable |
17,950,041.04 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
136,875,904.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
35,231,513.60 |
| Other Current Liabilities |
320,659.71 |
| Sub-Total of Current Liabilities |
486,538,282.20 |
| Long-term Loans |
271,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
79,623,775.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
529,122,809.77 |
| Total Liabilities |
1,015,661,091.97 |
| Paid-In Capital(Or Share Stock) |
491,178,800.00 |
| Capital Surplus |
1,558,583,912.96 |
| Surplus Reserve |
121,198,187.23 |
| LESS:Treasury Stock |
26,540,160.00 |
| Undistributed Profits |
914,311,552.66 |
| Minority Stockholder's Interest |
635,064,660.34 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,059,687,722.21 |
| Owner's Equity（Stockholder's Equity） |
3,694,752,382.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,710,413,474.52 |
